SUBSCRIBE
SUBSCRIBE
News   Business

Human Genome Sciences, Inc. Appoints Greg Norden to Its Board of Directors

January 21, 2011 | 
1 min read

ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences, Inc. (Nasdaq:HGSI) today announced that Greg Norden, former Senior Vice President and Chief Financial Officer of Wyeth, has been appointed to the HGS Board of Directors.

People
MORE ON THIS TOPIC
Sanofi's Distribution Center in Quebec, Canada
Radiopharmaceuticals
Sanofi Inks $326M Radiopharma Deal With Orano
October 17, 2024
 · 
2 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Layoff Tracker: Sage Therapeutics Will Lay Off 33% of Employees
October 17, 2024
 · 
167 min read
 · 
BioSpace Editorial Staff
Deerfield - Circa June 2019: Takeda Pharmaceutical Company. Takeda recently acquired Irish drugmaker Shire I
Huntington’s disease
Takeda Walks Away From Wave Huntington’s Partnership After Sinking $260M in Collaboration
October 16, 2024
 · 
3 min read
 · 
Tristan Manalac
Pictured: GSK laboratories in Dresden, Germany
Patents
GSK Sues Moderna for Alleged Patent Infringement on COVID-19, RSV Vaccines
October 16, 2024
 · 
2 min read
 · 
Tristan Manalac